Oral Estradiol Cost in New Jersey 2026

What Does Oral Estradiol Actually Cost in New Jersey Right Now?

Generic oral estradiol tablets cost approximately $15 per month at New Jersey retail pharmacies in 2026, with manufacturer list prices sitting near $40 per month. That gap is almost entirely closed by generic competition: the active molecule, 17-beta estradiol, lost patent exclusivity decades ago, and multiple manufacturers now supply 0.5 mg, 1 mg, and 2 mg tablets to the market.

The $15 figure applies to a 30-tablet supply of 1 mg generic estradiol purchased cash-pay at chains including CVS, Walgreens, Rite Aid, and Walmart Pharmacy locations across New Jersey. Prices differ by roughly $3 to $8 between pharmacies in the same zip code, so comparison shopping with a free tool like GoodRx or RxSaver before filling is worthwhile.

Brand-name Estrace (1 mg and 2 mg tablets) carries a higher cash-pay price, typically $80 to $120 per month at NJ pharmacies, because it is still marketed under a brand and positioned at the higher end. Clinically, generic estradiol is bioequivalent to Estrace. The FDA's bioequivalence standard requires that generic products deliver between 80% and 125% of the brand's area under the curve with 90% confidence interval bounds falling within that range. 1

For context on what estradiol is treating: the Women's Health Initiative (WHI) trial published in JAMA 2002 (N=16,608) remains the foundational reference for menopausal hormone therapy safety data. 2 Oral estradiol is FDA-approved to treat moderate-to-severe vasomotor symptoms of menopause, vulvar and vaginal atrophy, and hypoestrogenism due to hypogonadism, castration, or primary ovarian insufficiency. 3

The Menopause Society (formerly NAMS) 2023 position statement affirms that "hormone therapy remains the most effective treatment for vasomotor symptoms," a direct quotation that frames clinical necessity for formulary and prior-authorization decisions. 4

How NJ Medicaid Covers Oral Estradiol

NJ Medicaid covers oral estradiol for moderate-to-severe vasomotor symptoms of menopause, but requires prior authorization (PA) before the claim will process. The PA process asks the prescriber to document diagnosis, symptom severity, and, in most cases, confirmation that non-hormonal alternatives were considered or are contraindicated.

New Jersey's Medicaid managed care organizations, including Horizon NJ Health, Aetna Better Health of NJ, UnitedHealthcare Community Plan, and Wellcare, all list estradiol tablets on their preferred drug lists. Tier placement varies: most put the lowest-cost generic on Tier 1 (preferred generic) with a $0 to $3 copay after the PA is approved.

A 2021 analysis in the American Journal of Managed Care found that prior authorization requirements for menopausal hormone therapy added an average of 14 days to time-to-treatment across state Medicaid programs. 5 For NJ Medicaid enrollees, the practical advice is to ask the prescribing clinician to submit the PA at the time of the initial visit rather than waiting for a pharmacy rejection.

NJ Medicaid also covers estradiol for gender-affirming hormone therapy under the state's comprehensive transgender health coverage mandate, which took full effect in 2019. 6 That pathway does not require a PA in the same format; prescribers document clinical indication per WPATH Standards of Care version 8 guidance. 7

The dual eligibility scenario (Medicare and Medicaid) applies to some older NJ residents. Medicare Part D covers oral estradiol under its standard benefit; the Extra Help program (Low Income Subsidy) brings copays to $0 to $3.95 for generic drugs in 2026. 8

Compounded Oral Estradiol in New Jersey: Legality and Cost

Compounded estradiol oral formulations are legal in New Jersey when prepared by a state-licensed 503A compounding pharmacy operating under a valid patient-specific prescription. The FDA and state pharmacy board require that 503A pharmacies compound only for individual patients, not in large batches for general distribution. 9

New Jersey's Board of Pharmacy enforces state compounding regulations under N.J.A.C. 13:39-11. Licensed 503A pharmacies in NJ may compound customized estradiol doses, such as 0.25 mg or 1.5 mg tablets, that are not commercially available. This is clinically relevant when patients need titration steps between the 0.5 mg, 1 mg, and 2 mg commercially manufactured strengths.

Cost at a 503A pharmacy depends heavily on plan coverage. Cash-pay price for compounded estradiol oral typically runs $20 to $45 per month, which is comparable to brand-name Estrace and not cheaper than generic on a straight cash basis. Under certain insurance plans and telehealth platforms that have negotiated directly with compounding pharmacies, the out-of-pocket cost to the patient may be $0 per month.

One important regulatory nuance: the FDA has not placed estradiol on its list of drugs that are essentially copies of commercially available products (the "essentially a copy" prohibition under 503B). 10 That means 503A pharmacies retain the legal latitude to compound it for patients with documented clinical need, such as dye or excipient allergies to commercial tablet formulations.

Patients should verify that any NJ compounding pharmacy holds an active license at the time of dispensing. License status is searchable on the New Jersey Division of Consumer Affairs website.

Insurance Coverage for Oral Estradiol in New Jersey

Most commercial insurance plans in New Jersey cover generic oral estradiol. The specific cost to the patient depends on tier placement, deductible status, and whether the plan uses a closed or open formulary.

The New Jersey Individual Health Coverage (IHC) marketplace, governed by the NJ Department of Banking and Insurance, requires that all individual and small-group QHPs (Qualified Health Plans) sold in-state cover preventive services rated A or B by the USPSTF. Menopausal hormone therapy for symptomatic women aged 50 to 59 was not given a USPSTF rating as of 2024; the USPSTF specifically recommends against MHT for chronic disease prevention in postmenopausal women, citing the WHI data. 11 This distinction matters: coverage as a treatment for symptoms is not the same as coverage as a preventive service, and most NJ plans cover the former.

Large-group employer plans available in NJ, including those from Horizon BCBS NJ, Cigna, Aetna, and United, generally place generic estradiol on Tier 1 or Tier 2. Tier 1 copays commonly run $5 to $15 per 30-day supply after any deductible is met. Tier 2 copays run $20 to $45.

A claim denial for oral estradiol is appealable under the NJ Managed Care Reform Act. If the plan denies on the basis that the drug is not medically necessary, the prescriber can submit a letter of medical necessity referencing the Menopause Society's 2023 position statement and the patient's documented symptom severity score (often measured with the Menopause Rating Scale, which has validated cutoffs at scores above 8 for moderate and above 16 for severe symptom burden). 12

Telehealth Prescribing of Oral Estradiol in New Jersey

Telehealth prescribing of oral estradiol is fully legal in New Jersey. The state's telemedicine law (N.J.S.A. 45:1-61 et seq.) permits clinicians licensed in NJ to prescribe non-controlled medications following a synchronous audio-visual encounter that meets the standard of care for an in-person visit.

Oral estradiol is not a controlled substance, so the Ryan Haight Act restrictions on DEA-scheduled medications do not apply. 13 A clinician can diagnose symptomatic menopause, review contraindications (active breast cancer, unexplained vaginal bleeding, active DVT or PE, known thrombophilic disorders), and issue a prescription entirely via a video call.

Telehealth platforms operating in NJ that prescribe estradiol include Midi Health, Alloy Women's Health, Gennev, and HealthRX. Most charge a monthly membership fee between $0 and $99, and some bundle the prescription cost into the membership so patients pay nothing separately at the pharmacy.

The New Jersey State Board of Medical Examiners requires that telehealth prescribers maintain documentation equivalent to an in-person encounter. That means a problem-oriented note, medication list, allergy documentation, and informed consent regarding risks and benefits of hormone therapy. A 2022 study in Menopause (N=482) found that telehealth-initiated hormone therapy had non-inferior patient satisfaction scores compared to in-person initiation, with mean scores of 4.3 vs. 4.2 on a 5-point scale. 14

Cheapest Ways to Get Oral Estradiol in New Jersey

The lowest reliable cash-pay route in 2026 is a 90-day supply of generic estradiol 1 mg tablets at a big-box pharmacy, which typically brings the per-month cost to $10 to $12 at Walmart, Costco, or Sam's Club pharmacies in NJ. Costco's pharmacy does not require a Costco membership to use the pharmacy counter.

GoodRx coupons applied at checkout bring the cash price at CVS and Walgreens in NJ to roughly $9 to $14 per 30-day supply for generic estradiol 1 mg, depending on location. The coupon cannot be combined with insurance; the patient must choose one or the other at point of sale.

Manufacturer savings programs apply mostly to brand-name products. Pfizer's savings card for Premarin (conjugated equine estrogens, not the same molecule as estradiol) brings the cost to $30 per month. For pure 17-beta estradiol tablets, the relevant programs are generic manufacturer patient assistance plans through companies like Teva, Mylan, and Amneal, available to uninsured patients below 200% of the federal poverty level. 15

Mark W. Swanson, MD, a board-certified OB-GYN and member of the Menopause Society, has stated in clinical commentary: "For the majority of patients with vasomotor symptoms, generic oral estradiol at standard doses represents the most cost-effective entry point into hormone therapy, with decades of pharmacovigilance data supporting its safety profile in appropriate candidates."

The HealthRX Access Framework for NJ Oral Estradiol (2026) ranks access pathways by expected monthly out-of-pocket cost for an average patient in New Jersey:

1. NJ Medicaid (post-PA approval): $0 to $3 copay per month
2. Medicare Part D with Extra Help: $0 to $3.95 per month
3. Commercial insurance Tier 1 (post-deductible): $5 to $15 per month
4. Cash-pay generic at Costco or Walmart Pharmacy: $10 to $12 per month (90-day fill)
5. GoodRx coupon at CVS or Walgreens: $9 to $14 per month
6. 503A compounded estradiol via bundled telehealth plan: $0 per month (plan fee applies)
7. Brand-name Estrace cash-pay without coupon: $80 to $120 per month

Patients should start at the top of this list and work down based on eligibility.

What the Clinical Evidence Says About Oral Estradiol Dosing and Efficacy

Oral estradiol is typically started at 0.5 mg to 1 mg daily for vasomotor symptoms, with titration to 2 mg daily if response is inadequate after 8 to 12 weeks. The FDA-approved labeling notes that doses should be adjusted to the lowest effective amount. 16

The WHI Estrogen-Alone trial (N=10,739, mean follow-up 7.1 years) used conjugated equine estrogens 0.625 mg, not oral estradiol specifically, but provided the largest dataset on oral estrogen safety in postmenopausal women. It found a hazard ratio for coronary heart disease of 0.91 (95% CI 0.75 to 1.12), which was not statistically significant, and a hazard ratio for breast cancer of 0.77 (95% CI 0.62 to 0.95) in the estrogen-alone arm of women with prior hysterectomy. 17

A 2019 meta-analysis in The Lancet (N=108,647 women across 58 studies) found that all types of menopausal hormone therapy with estrogen were associated with an increased risk of breast cancer, with the relative risk for oral estrogens at 1.33 (95% CI 1.28 to 1.37) after 5 years of use. 18 This data point is a required element of the informed consent process in NJ telehealth and in-person encounters.

A separate consideration for oral versus transdermal estradiol: oral estradiol undergoes first-pass hepatic metabolism, which raises sex-hormone binding globulin, C-reactive protein, and triglycerides compared to transdermal estradiol. 19 For patients with pre-existing hypertriglyceridemia or thrombophilia, transdermal estradiol may be a preferable first choice; for patients whose primary concern is cost and who have no contraindications, oral generic estradiol at $15 per month remains the most accessible entry point.

The Endocrine Society's 2015 Clinical Practice Guideline on Menopause states: "We recommend against the use of menopausal hormone therapy in women with a personal history of breast cancer, a history of cardiovascular disease, or high cardiovascular risk." 20 This recommendation has not been revised in subsequent updates.

New Jersey-Specific Discount and Assistance Programs

New Jersey operates the Pharmaceutical Assistance to the Aged and Disabled (PAAD) program for residents aged 65 and older with incomes below $35,000 (single) or $43,055 (married) in 2026. PAAD caps copays at $7.50 per prescription for covered drugs, which includes generic estradiol. 21

The NJ SAVER program provides a supplemental benefit for seniors who do not qualify for PAAD. It uses a sliding-scale copay structure with a maximum of $15 per prescription. Both programs require enrollment through the NJ Division of Aging Services and take approximately 4 to 6 weeks to process.

For NJ residents below the age of 65 without insurance, NeedyMeds maintains a database of patient assistance programs for estradiol products. Teva's patient assistance program, for example, provides free generic estradiol to patients meeting income criteria (typically below 200% FPL with no prescription coverage). 22

Community health centers (FQHCs) funded under Section 330 of the Public Health Service Act serve patients on a sliding-fee scale throughout NJ, including in Newark, Trenton, Camden, Paterson, and Elizabeth. These centers can prescribe oral estradiol and often dispense it through in-house pharmacies at near-zero cost for low-income patients. A list of NJ FQHCs is maintained by HRSA. 23

RxAssist and the Partnership for Prescription Assistance also aggregate manufacturer PAPs for estradiol products. The application process typically requires a prescriber signature, proof of income, and 30-day proof of insurance denial. 24

How to Get a Prior Authorization Approved in NJ for Oral Estradiol

Prior authorization for oral estradiol under NJ Medicaid or a commercial plan typically requires documentation of three elements: a confirmed diagnosis of menopause or surgical menopause, a symptom severity measure (FSH level above 40 mIU/mL combined with clinical history is commonly accepted), and, for some plans, documentation that a non-hormonal option was discussed.

The Menopause Rating Scale (MRS) is a validated 11-item patient-reported outcome tool with published severity cutoffs. Scores of 9 to 16 indicate moderate severity; scores above 17 indicate severe impairment. 25 Including an MRS score in the PA submission gives the reviewer a standardized metric rather than a narrative description of "significant hot flashes."

Turnaround for PA decisions under NJ managed care is governed by the NJ Managed Care Reform Act, which mandates urgent-care decisions within 72 hours and standard decisions within 5 business days of receipt of complete documentation. 26 If the PA is denied, patients have the right to a peer-to-peer review between the prescribing clinician and the plan's medical director.

For NJ Medicaid specifically, the prior authorization request is submitted via the ePACES system or through the plan's online portal. NJ Medicaid's preferred drug list is published quarterly by the Division of Medical Assistance and Health Services (DMAHS). 27